Human growth hormone (HGH) is covered by insurance, but only for a narrow list of FDA-approved medical conditions. If your doctor prescribes it for anti-aging, bodybuilding, weight loss, or general wellness, your insurer will deny the claim every time. Coverage hinges entirely on your diagnosis and whether you can document it with specific lab tests.
Conditions Insurance Will Cover
Insurers recognize roughly a dozen diagnoses as eligible for HGH coverage. The most common are growth hormone deficiency in children and adults, Turner syndrome, Prader-Willi syndrome, Noonan syndrome, chronic kidney disease causing growth failure in children, being born small for gestational age, and SHOX deficiency (a genetic condition affecting bone growth). HIV-related wasting and cachexia also qualify, and Medicare Part D specifically covers growth hormone for that indication.
Adult growth hormone deficiency is covered, but insurers scrutinize these claims more heavily than pediatric ones. You’ll need to prove your body doesn’t produce enough growth hormone through standardized stimulation testing, not just a single blood draw. For adults, a failed stimulation test typically means your growth hormone peaked below 5 ng/mL. For children, the threshold is below 10 ng/mL, and most insurers require you to fail at least two separate stimulation tests before they’ll approve treatment.
One important gap: idiopathic short stature, meaning a child is significantly short but doctors can’t identify a hormonal or genetic cause. Major insurers like Aetna do not consider this an illness, disease, or injury, so coverage isn’t available under most plans even though the FDA technically approved HGH for this use.
What Insurance Will Not Cover
The list of excluded uses is long. Insurers consider HGH experimental or unproven for anti-aging, athletic enhancement, bodybuilding, obesity, osteoporosis, chronic fatigue syndrome, fibromyalgia, depression, infertility, burn injuries, Crohn’s disease, and traumatic brain injury (unless it caused growth hormone deficiency in a child). Using HGH to build muscle or slow aging isn’t just uncovered; distributing it for those purposes actually violates federal law. The FDA has never approved HGH for anti-aging or performance enhancement, and some pharmacies that market compounded HGH products for these purposes are operating outside the law.
The Prior Authorization Process
Almost every insurer requires prior authorization before they’ll pay for HGH. This means your doctor submits documentation proving you meet the medical criteria, and the insurance company reviews it before approving the prescription. Expect the process to take days to weeks.
For children, your doctor will typically need to submit the diagnosis code, results from at least two growth hormone stimulation tests, bone age X-rays showing the growth plates haven’t closed (generally bone age under 16 for boys and under 14 for girls), and growth chart records. For renewal requests, insurers want to see that treatment is working, usually defined as a growth rate above 2.5 centimeters per year, and that the growth plates are still open.
For adults, the documentation requirements focus on stimulation test results and symptoms of deficiency like fatigue, reduced bone density, or changes in body composition. If you had childhood-onset deficiency, you may need to be retested as an adult after a washout period of one to three months off treatment to confirm you still need it.
What to Do if Your Claim Is Denied
Denials are common with HGH, even for legitimate diagnoses, often because paperwork is incomplete or test results don’t clearly meet the insurer’s thresholds. You have two levels of appeal available under federal law.
The first is an internal appeal, where you ask the insurance company to reconsider its decision. Your insurer is required to conduct a full review, and if your situation is medically urgent, they must expedite it. The strongest internal appeals include a detailed letter from your endocrinologist explaining why the treatment is medically necessary, along with all supporting lab work and imaging.
If the internal appeal fails, you can request an external review, where an independent third party evaluates the case. At this stage, the insurance company no longer has the final say. Your insurer is legally required to tell you why they denied your claim and how to initiate both types of appeal.
Out-of-Pocket Costs and Patient Assistance
HGH is expensive. Without insurance, treatment can run anywhere from $500 to over $3,000 per month depending on the brand and dose. Even with coverage, copays and coinsurance can be significant, especially if your plan places HGH in a specialty drug tier.
Several manufacturers offer patient assistance programs that provide HGH at no cost to eligible patients. Pfizer’s RxPathways program covers Genotropin for patients earning up to 400% of the federal poverty level who lack adequate prescription coverage. Novartis offers a similar program for Omnitrope at the same income threshold. Lilly Cares provides Humatrope to patients with no prescription coverage and income at or below 300% of the federal poverty level, which works out to roughly $38,280 per year for a single person. These programs typically ship medication directly to your doctor’s office in multi-month supplies and require annual re-enrollment.
If you have Medicare Part D, Lilly’s program requires you to have spent at least $1,100 on medications in a calendar year before you become eligible. Other Medicare types generally don’t qualify for manufacturer assistance, though Part D does cover HGH for approved indications like HIV wasting.